The COGNIL brand, founded in 2012 (Czech Republic), from 2757 sister brands and 17477 competing brands. COGNIL is a brand of Sanofi, listed on the stock exchange of Paris. The ISIN, the company's International Securities Identification Number, is FR0000120578. COGNIL belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Sanofi
(COGNIL)
over 5 years*
EUR 107.32